Glaukos Corporation - stock earnings
GKOS Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 1, 2024 AfterMarket | -0.70 / -0.59 | - | 85.6 million / 81.2 million | - |
GKOS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -36.8 million USD | 82.4 million USD |
| 2023Q3 | -30.4 million USD | 78.0 million USD |
| 2023Q2 | -32.8 million USD | 80.4 million USD |
| 2023Q1 | -34.6 million USD | 73.9 million USD |
| 2022Q4 | -31.5 million USD | 71.2 million USD |
| 2022Q3 | -27.6 million USD | 71.3 million USD |
| 2022Q2 | -45.5 million USD | 72.7 million USD |
| 2022Q1 | 5.4 million USD | 67.7 million USD |
| 2021Q4 | -21.9 million USD | 73.2 million USD |
| 2021Q3 | 6.2 million USD | 74.7 million USD |
| 2021Q2 | -17.5 million USD | 78.1 million USD |
| 2021Q1 | -16.5 million USD | 68.0 million USD |
| 2020Q4 | -10.6 million USD | 73.2 million USD |
| 2020Q3 | -15.7 million USD | 64.8 million USD |
| 2020Q2 | -39.9 million USD | 31.6 million USD |
| 2020Q1 | -54.1 million USD | 55.3 million USD |
| 2019Q4 | 36.6 million USD | 65.8 million USD |
| 2019Q3 | -13.5 million USD | 58.5 million USD |
| 2019Q2 | -6.3 million USD | 58.6 million USD |
| 2019Q1 | -1.3 million USD | 54.0 million USD |
| 2018Q4 | 1.8 million USD | 54.1 million USD |
| 2018Q3 | -6.6 million USD | 43.9 million USD |
| 2018Q2 | -5.4 million USD | 43.2 million USD |
| 2018Q1 | -2.7 million USD | 40.1 million USD |
| 2017Q4 | 1.0 million USD | 41.7 million USD |
| 2017Q3 | 1.3 million USD | 40.4 million USD |
| 2017Q2 | -3.3 million USD | 41.3 million USD |
| 2017Q1 | 878000 USD | 35.9 million USD |
| 2016Q4 | 134000 USD | 33.2 million USD |
| 2016Q3 | 1.2 million USD | 29.6 million USD |
| 2016Q2 | 2.3 million USD | 28.6 million USD |
| 2016Q1 | 897000 USD | 23.1 million USD |
| 2015Q4 | -2.3 million USD | 20.3 million USD |
| 2015Q3 | -2.1 million USD | 19.0 million USD |
| 2015Q2 | -31.9 million USD | 17.8 million USD |
| 2015Q1 | -966000 USD | 14.7 million USD |
| 2014Q4 | -4.6 million USD | 14.1 million USD |
| 2014Q3 | -1.5 million USD | 12.1 million USD |
| 2014Q2 | -2.1 million USD | 11.1 million USD |
| 2014Q1 | -4.0 million USD | 8.2 million USD |
| 2013Q4 | ? USD | 7.1 million USD |
| 2013Q3 | ? USD | 6.1 million USD |
| 2013Q2 | ? USD | 4.9 million USD |
| 2013Q1 | ? USD | 2.9 million USD |
GKOS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -134.7 million USD | 314.7 million USD |
| 2022 | -99.2 million USD | 282.9 million USD |
| 2021 | -49.6 million USD | 294.0 million USD |
| 2020 | -120.3 million USD | 225.0 million USD |
| 2019 | 15.4 million USD | 237.0 million USD |
| 2018 | -13.0 million USD | 181.3 million USD |
| 2017 | -92000 USD | 159.3 million USD |
| 2016 | 4.5 million USD | 114.4 million USD |
| 2015 | -37.2 million USD | 71.7 million USD |
| 2014 | -12.1 million USD | 45.6 million USD |
| 2013 | -12.6 million USD | 20.9 million USD |
GKOS
Price: $98.91
52 week price:
Earnings Per Share: -2.78 USD
P/E Ratio: -35.68
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Volume: 62314
Ebitda: 2.3 millionMarket Capitalization: 5.0 billion